Eli Lilly (NYSE: LLY) reported earnings on Jan. 31. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Eli Lilly beat expectations on revenue and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue contracted slightly, and GAAP earnings per share improved.

Margins contracted across the board.

Revenue details
Eli Lilly reported revenue of $6.05 billion. The 15 analysts polled by S&P Capital IQ foresaw revenue of $5.90 billion. Sales were 2.3% lower than the prior-year quarter's $6.19 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions.

EPS details
Non-GAAP EPS came in at $0.87. The 18 earnings estimates compiled by S&P Capital IQ averaged $0.81 per share on the same basis. GAAP EPS of $0.87 for Q4 were 27% lower than the prior-year quarter's $1.05 per share.

Source: S&P Capital IQ. Quarterly periods. Figures may be non-GAAP to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 78.1%, 200 basis points worse than the prior-year quarter. Operating margin was 20.4%, 430 basis points worse than the prior-year quarter. Net margin was 14.2%, 470 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $5.30 billion. On the bottom line, the average EPS estimate is $0.78.

Next year's average estimate for revenue is $22.35 billion. The average EPS estimate is $3.19.

Investor sentiment
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Eli Lilly is hold, with an average price target of $37.37.

Can your retirement portfolio provide you with enough income to last? You'll need more than Eli Lilly. Learn about crafting a smarter retirement plan in "The Shocking Can't-Miss Truth About Your Retirement." Click here for instant access to this free report.